KIPF, the majority shareholder of the WSE-listed pharma distributor Pelion will buy back the remaining 8.27 million shares with the price set at PLN 52.33 apiece. KIPF, along with the company’s owners controls 25.77 percent of capital and 54.13 percent voting rights. The tender will go through if at least 6.54 million shares are sold….
- Poland AM
- Our Products